Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 95469568 | 9546956 | 8 | F | 20130206 | 20160913 | 20130924 | 20160920 | EXP | CA-ROCHE-1279640 | ROCHE | 64.44 | YR | M | Y | 0.00000 | 20160921 | MD | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 95469568 | 9546956 | 1 | PS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | S0002F | 103976 | 300 | MG | SOLUTION FOR INJECTION | |||||||
| 95469568 | 9546956 | 2 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | UNK | S0002F | 103976 | SOLUTION FOR INJECTION | ||||||||
| 95469568 | 9546956 | 3 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | S0002F | 103976 | SOLUTION FOR INJECTION | |||||||||
| 95469568 | 9546956 | 4 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | S0002F | 103976 | SOLUTION FOR INJECTION | |||||||||
| 95469568 | 9546956 | 5 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | S0002F | 103976 | SOLUTION FOR INJECTION | |||||||||
| 95469568 | 9546956 | 6 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | S0002F | 103976 | SOLUTION FOR INJECTION | |||||||||
| 95469568 | 9546956 | 7 | SS | XOLAIR | OMALIZUMAB | 1 | Unknown | S0002F | 103976 | SOLUTION FOR INJECTION | |||||||||
| 95469568 | 9546956 | 8 | SS | XOLAIR | OMALIZUMAB | 1 | Unknown | UNK | S0002F | 103976 | SOLUTION FOR INJECTION | ||||||||
| 95469568 | 9546956 | 9 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | S0002F | 103976 | 300 | MG | SOLUTION FOR INJECTION | |||||||
| 95469568 | 9546956 | 10 | SS | TAMSULOSIN SANDOZ | TAMSULOSIN | 1 | Unknown | U | 0 | .4 | MG | QD | |||||||
| 95469568 | 9546956 | 11 | SS | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | Unknown | BEFORE BREAKFAST?REPORTED AS PANTOPRAZOLE SANDOZ | U | 0 | 20 | MG | |||||||
| 95469568 | 9546956 | 12 | C | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Unknown | 2 PUFFS, BID | U | 0 | 2 | DF | BID | ||||||
| 95469568 | 9546956 | 13 | C | SINGULAIR | MONTELUKAST SODIUM | 1 | Oral | 10 MG, QHS | U | 0 | 10 | MG | |||||||
| 95469568 | 9546956 | 14 | C | FUROSEMIDE TEVA | FUROSEMIDE | 1 | Unknown | U | 0 | ||||||||||
| 95469568 | 9546956 | 15 | C | APO-PREDNISONE | PREDNISONE | 1 | Unknown | U | 0 | ||||||||||
| 95469568 | 9546956 | 16 | C | APO-CLOPIDOGREL | CLOPIDOGREL BISULFATE | 1 | Unknown | U | 0 | ||||||||||
| 95469568 | 9546956 | 17 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | Unknown | U | 0 | ||||||||||
| 95469568 | 9546956 | 18 | C | APO-ATORVASTATIN | ATORVASTATIN | 1 | Unknown | U | 0 | ||||||||||
| 95469568 | 9546956 | 19 | C | METOPROLOL. | METOPROLOL | 1 | Unknown | REPORTED AS METOPROLOL TEVA | U | 0 | |||||||||
| 95469568 | 9546956 | 20 | C | ASA | ASPIRIN | 1 | Unknown | U | 0 | ||||||||||
| 95469568 | 9546956 | 21 | C | SLOW K | POTASSIUM CHLORIDE | 1 | Unknown | U | 0 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 95469568 | 9546956 | 1 | Asthma |
| 95469568 | 9546956 | 10 | Urine flow decreased |
| 95469568 | 9546956 | 11 | Gastrointestinal disorder |
| 95469568 | 9546956 | 12 | Product used for unknown indication |
| 95469568 | 9546956 | 13 | Product used for unknown indication |
| 95469568 | 9546956 | 14 | Product used for unknown indication |
| 95469568 | 9546956 | 15 | Product used for unknown indication |
| 95469568 | 9546956 | 16 | Product used for unknown indication |
| 95469568 | 9546956 | 17 | Product used for unknown indication |
| 95469568 | 9546956 | 18 | Product used for unknown indication |
| 95469568 | 9546956 | 19 | Product used for unknown indication |
| 95469568 | 9546956 | 20 | Product used for unknown indication |
| 95469568 | 9546956 | 21 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 95469568 | 9546956 | HO |
| 95469568 | 9546956 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 95469568 | 9546956 | Chest discomfort | |
| 95469568 | 9546956 | Chest pain | |
| 95469568 | 9546956 | Heart rate increased | |
| 95469568 | 9546956 | Hypertension | |
| 95469568 | 9546956 | Myocardial infarction |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 95469568 | 9546956 | 1 | 20110727 | 0 | ||
| 95469568 | 9546956 | 2 | 20130529 | 0 | ||
| 95469568 | 9546956 | 3 | 20130206 | 0 | ||
| 95469568 | 9546956 | 4 | 20130501 | 0 | ||
| 95469568 | 9546956 | 5 | 20130918 | 0 | ||
| 95469568 | 9546956 | 6 | 20131113 | 0 | ||
| 95469568 | 9546956 | 7 | 20131211 | 0 | ||
| 95469568 | 9546956 | 8 | 20140108 | 0 | ||
| 95469568 | 9546956 | 9 | 20160628 | 0 |